Speaking with MedImmune’s President, Peter Greenleaf, pharmaphorum finds that the challenges and opportunities faced by MedImmune in developing commercially successful biological therapies in ...

Joining me on the call this morning are Peter Greenleaf, Aurinia's President and Chief Executive Officer; Joe Miller, our ...

Aurinia Pharmaceuticals Inc. (NASDAQ: NASDAQ:AUPH) demonstrated a significant financial turnaround in its Third Quarter 2024 Earnings Call, with CEO Peter Greenleaf, CFO Joe Miller, and CMO Dr ...

Joining me on the call this morning are Peter Greenleaf, Aurinia's President and Chief Executive Officer; Joe Miller, our Chief Financial Officer; and Dr. Greg Keenan, our Chief Medical Officer.

Aurinia Pharmaceuticals Inc. (NASDAQ: NASDAQ:AUPH) demonstrated a significant financial turnaround in its Third Quarter 2024 Earnings Call, with CEO Peter Greenleaf, CFO Joe Miller, and CMO Dr. Greg ...